阅读说明：本技术 一种cdk激酶抑制剂及其应用 (CDK kinase inhibitor and application thereof ) 是由 林星雨 陆婷婷 于 2020-03-26 设计创作，主要内容包括：本发明公开了一种通式为Ⅰ的化合物,或其药学上可接受的盐、立体异构体、酯、前药、溶剂化物和氘代化合物,及其含有通式为Ⅰ的化合物的组合物,以及通式为Ⅰ的化合物,或其药学上可接受的盐、立体异构体、酯、前药、溶剂化物和氘代化合物在制备治疗一种或多种细胞周期蛋白依赖激酶相关的疾病的药物中的应用。(The invention discloses a compound with a general formula I, or pharmaceutically acceptable salts, stereoisomers, esters, prodrugs, solvates and deuterated compounds thereof, a composition containing the compound with the general formula I, and application of the compound with the general formula I, or pharmaceutically acceptable salts, stereoisomers, esters, prodrugs, solvates and deuterated compounds thereof in preparation of medicines for treating one or more diseases related to cyclin dependent kinases.)